Induced pluripotent stem cell (iPS cell), immature cell that is generated from an adult (mature) cell and that has regained the capacity to differentiate into any type of cell in the body. Induced pluripotent stem cells (iPS cells) differ from embryonic stem cells (ES cells), which form the inner cell mass of an embryo but also are pluripotent, eventually giving rise to all the cell types that make up the body.
Pluripotent stem cell generated directly from a somatic cell Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from a somatic cell. The iPSC technology was pioneered by Shinya Yamanakas lab in Kyoto, Japan, who showed in 2006 that the introduction of four specific genes (named Myc, Oct3/4, Sox2 and Klf4) encoding transcription factors could convert somatic cells into pluripotent stem cells.[1] He was awarded the 2012 Nobel Prize along with Sir John Gurdon "for the discovery that mature cells can be reprogrammed to become pluripotent."[2] Pluripotent stem cells hold promise in the field of regenerative medicine.[3] Because they can propagate indefinitely, as well as give rise to every other cell type in the body (such as neurons, heart, pancreatic, and liver cells), they represent a single source of cells that could be used to replace those lost to damage or disease.
Charles A. Goldthwaite, Jr., Ph.D.
iPSC are derived from skin or blood cells that have been reprogrammed back into an embryonic-like pluripotent state that enables the development of an unlimited source of any type of human cell needed for therapeutic purposes. For example, iPSC can be prodded into becoming beta islet cells to treat diabetes, blood cells to create new blood free of cancer cells for a leukemia patient, or neurons to treat neurological disorders. In late 2007, a BSCRC team of faculty, Drs.
Induced pluripotent stem cells (iPSCs) are adult cells that have been genetically reprogrammed to an embryonic stem celllike state by being forced to express genes and factors important for maintaining the defining properties of embryonic stem cells. Although these cells meet the defining criteria for pluripotent stem cells, it is not known if iPSCs and embryonic stem cells differ in clinically significant ways
An important step in developing a therapy for a given disease is understanding exactly how the disease works: what exactly goes wrong in the body? To do this, researchers need to study the cells or tissues affected by the disease, but this is not always as simple as it sounds
Acta Naturae. 2010 Jul; 2(2): 1828. Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences Research Center of Clinical and Experimental Medicine, Siberian Branch, Russian Academy of Medical Sciences Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences Research Center of Clinical and Experimental Medicine, Siberian Branch, Russian Academy of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
Stem Cell Research Morally Wrong There are bugs or theres something that goes wrong to stem cell researchers, including myself, underscores the synergy that results when we reach across disciplines. The Santa Barbara-based event covers By contrast, the public is much less likely Stem Cells and Growth Factors: What You Should Know However, there remains a great deal of confusion about the differences between growth factors, stem cells, plant stem cells and other related technologies. This article will discuss the pros and cons of This is known as induced pluripotent stem cells While embryonic stem cells may turn out to be the best choice for some therapies, research work with other stem cell system, such as iPS cells and adult stem "Stem Cell Research Pros and Cons." Scientific Method Understanding Science The third and most recently discovered source is adult stem cells, or induced pluripotent stem cells (iPS).
The developers of the lung epithelium model plan to investigate whether SARS-CoV-2 can infect and replicate in the model to assess whether it could be used in the fight against COVID-19. A biotech company has announced they are testing whether their human lung epithelium model could be used as a platform for investigating SARS-CoV-2 infection and developing and evaluating potential antiviral strategies for COVID-19. Newcells Biotech based their lung epithelium organoid on human induced pluripotent stem cells (hiPSC) and have been developing the model for two years.
A new, safe and efficient way to coax stem cells into bone cells is reported in a recently published article from STEM CELLS Translational Medicine (SCTM). DURHAM, N.C., Jan.
Recent Comments